Thomas A. Abrams

Oncology
300 Boylston St
Chestnut Hill, MA 02467

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma.

Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma.

Journal: JAMA network open
Published: December 30, 2025

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Journal: Cancer discovery
Published: September 23, 2025

Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2025

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Journal: JCO precision oncology
Published: September 02, 2025

Racial and ethnic differences in treatment and survival for hepatocellular carcinoma patients undergoing systemic therapy.

Racial and ethnic differences in treatment and survival for hepatocellular carcinoma patients undergoing systemic therapy.

Journal: JNCI cancer spectrum
Published: August 01, 2025

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025

Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET).

Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030.

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030.

Journal: Journal of hepatocellular carcinoma
Published: March 14, 2025

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

Journal: Nature cancer
Published: January 01, 2025

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Journal: medRxiv : the preprint server for health sciences
Published: October 17, 2024

Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.

Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.

Journal: Future oncology (London, England)
Published: June 17, 2024

Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study.

Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study.

Journal: Cancer
Published: June 17, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026